Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 14,060

Document Document Title
WO/2013/077385
An aromatic amine derivative represented by the general formula (1). In the general formula (1), R1-R5 and R7-R11 are each independently hydrogen atoms or substituents. In the general formula (1), R6 and R12 are represented by the genera...  
WO/2013/075399
Provided in the present invention are an unsaturated 5-membered benzo-heterocyclic compound with the structure as shown in general formula I or pharmaceutical salts thereof, and a preparation method, a pharmaceutical composition and the ...  
WO/2013/075596
The present invention relates to the synthesis and use of a pentabasic dihydrogen heterocyclic ketone derivative of general formula (I) used as a DHODH inhibitor for Plasmodium falciparum, and the compound related to the present inventio...  
WO/2013/075253
The present application provides compound of Formula (X) wherein A is an optionally substituted aliphatic or an optionally substituted aryl, and B is a moiety that stabilizes the partial positive charge at the carbon adjacent the divalen...  
WO/2013/076747
A process is described for the production of 1,4-butanediol and tetrahydrofuran by catalytic hydrogenation of dialkyl maleates. The process consists essentially in the following steps: a) hydrogenating a stream of dialkyl maleate in a fi...  
WO/2013/077405
Provided is an aromatic amine derivative represented by general formula (1). In general formula (1), R2 to R5, R7 to R9, and R10 are each a hydrogen atom or a substituent. R1 and R6 in general formula (1) are represented by general formu...  
WO/2013/077406
Provided is an aromatic amine derivatives represented by general formula (1). In general formula (1), R2 to R5, R7 to R9, and R10 are each a hydrogen atom or a substituent. R1 and R6 in general formula (1) are represented by general form...  
WO/2013/072830
The present invention discloses single step, highly enantioselective catalytic oxidative cyclization process for the synthesis of 3-substituted chiral phthalides. In particular, the invention discloses asymmetric synthesis of chiral phth...  
WO/2013/072830
The present invention discloses single step, highly enantioselective catalytic oxidative cyclization process for the synthesis of 3-substituted chiral phthalides. In particular, the invention discloses asymmetric synthesis of chiral phth...  
WO/2013/072830
The present invention discloses single step, highly enantioselective catalytic oxidative cyclization process for the synthesis of 3-substituted chiral phthalides. In particular, the invention discloses asymmetric synthesis of chiral phth...  
WO/2013/069646
The purpose of the invention is to provide a polyimide offering excellent solubility in organic solvents, an acid dianhydride compound that is a monomer thereof, and a method for producing the same. An acid dianhydride represented by for...  
WO/2013/067578
Heterocyclic compounds that modulate C3a receptors and their use in the treatment or prevention of inflammatory diseases, infectious diseases, cancers, metabolic disorders, obesity, type 2 diabetes, metabolic syndrome and associated card...  
WO/2013/066776
Processes for producing 5-(hydroxymethyl)furfural are provided. 5-(hydroxymethyl)furfural is a potential platform intermediate in the conversion of biomass to renewable chemicals. The processes use hexoses in an aqueous solution comprisi...  
WO/2013/066541
Processes for producing furfural from biomass are provided. The processes use a metal halide in aqueous solutions of water-miscible and can provide a furfural yield of greater than 70%.  
WO/2013/064610
The invention relates to a process for the production of gamma-valerolactone (GVL) by gas phase hydrogenation of furfural or furfuryl alcohol in the presence of a solid catalyst. The conversion of furfural or furfuryl alcohol to GVL is c...  
WO/2013/064751
The present invention relates to a method and an arrangement for separation and recovery of at least one carboxylic acid and furfural from a dilute aqueous mixture thereof. In the method of the present invention a dilute aqueous mixture ...  
WO/2013/065835
A compound represented by general formula (I) or a pharmaceutically acceptable salt thereof. This novel compound has an ability of activating a glycogen synthase, but rarely activates a receptor, i.e., a PPAR, and is highly safe. (In the...  
WO/2013/061724
Provided are a novel radical inhibitor, a composition containing the same, and a radical generation inhibition method using the same. This radical inhibitor comprises a salen complex compound of a divalent metal.  
WO/2013/061962
The present invention provides a compound represented by formula (I) or a salt thereof. (In the formula, the symbols are as defined in the description.)  
WO/2013/060860
The present invention relates to compounds having the general formula (I) as described herein; methods of preparing said compounds; and their use in treating Type 1 and/or Type 2 Diabetes Mellitus. The compounds were assayed for binding ...  
WO/2013/061004
The present invention relates to novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds corresponding to the following general formula (I): , to the pharmaceutical compositions containing these compounds and also to the use of...  
WO/2013/061224
The present invention provides a novel process and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren, or a salt thereof, preferably Aliskiren hemifumarate.  
WO/2013/061004
The present invention relates to novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds corresponding to the following general formula (I): , to the pharmaceutical compositions containing these compounds and also to the use of...  
WO/2013/059582
The disclosure relates to small molecules and methods, compositions, and kits comprising these small molecules. In still another embodiment, the disclosure relates to small molecules that inhibit HDAC activity. In yet another embodiment,...  
WO/2013/058631
The present invention relates to a diterpene furanoids compound which inhibits an activity of protein tyrosine phosphatase 1B (PTP1B) and to the use thereof. More particularly, the present invention relates to diterpene furanoids which a...  
WO/2013/059582
The disclosure relates to small molecules and methods, compositions, and kits comprising these small molecules. In still another embodiment, the disclosure relates to small molecules that inhibit HDAC activity. In yet another embodiment,...  
WO/2013/059215
Disclosed herein are substituted biaryl alkyl amide compounds, methods of synthesizing substituted biaryl alkyl amide compounds and methods of treating diseases and/or conditions with substituted biaryl alkyl amide compounds.  
WO/2013/058631
The present invention relates to a diterpene furanoids compound which inhibits an activity of protein tyrosine phosphatase 1B (PTP1B) and to the use thereof. More particularly, the present invention relates to diterpene furanoids which a...  
WO/2013/053046
The present application, relates to iron bisphenolate complexes and methods of use and synthesis thereof. The iron complexes are prepared from tridentate or tetradentate ligands of Formula I: wherein R1 and R2 are as defined herein. Also...  
WO/2013/053287
(-)-(S)-3-(3'-hydroxy)-butylphthalide (a compound shown by Formula I) and an ester formed of the same and an acid are proved by experiments to be applicable to treatment and prevention of cerebral ischemic diseases and have a sleep-impro...  
WO/2013/053816
The present invention relates to a process for producing 5-hydroxymethylfurfural (HMF) from fructose in a single-phase aqueous solution comprising an organic solvent.  
WO/2013/055577
The present invention provides novel selective androgen receptor modulators and their salts and pharmaceutical compositions thereof.  
WO/2013/050301
The present invention relates to processes for the enantio-selective preparation of spyrrolidine derivatives useful in the manufacture of pesticidally active compounds, as well as to intermedates in the processes. The processes include t...  
WO/2013/044371
A compound according to Formula IA and IB, reversibly convertible under photochromic and electrochromic conditions between a ring-open isomer A and a ring-closed isomer B is provided. For substitutent groups, Z is N, O or S; each R1 is i...  
WO/2013/047904
The present invention provides a novel compound having a control efficacy on harmful arthropods. A compound represented by Formula (I): wherein Y represents a 3-7-membered saturated heterocyclic group containing one or more atoms or grou...  
WO/2013/049711
Provided are methods of producing 2,5-furandicarboxylic acid (FDCA) from renewable sources such as seaweed, alginate, oligoalginate, pectin, oligopectin, polygalacturonate, galacturonate, and/or oligogalacturonate. The sugars in the rene...  
WO/2013/047055
Provided is a heat shock protein expression inducer based on a heat shock protein (HSP) expression-inducing action. The present invention is a heat shock protein (HSP) expression inducer comprising eupalinolide A and/or B, the heat shock...  
WO/2013/047044
The present invention is a composition for forming a film for liquid-immersion exposure, said composition containing the following: a polymer component (A) containing a polymer (a1) that has a constitutional unit (I) represented by diagr...  
WO/2013/047984
The present invention relates to a method for producing a furan-based compound using an ion exchange resin in the presence of an organic solvent. In the method for producing a furan-based compound according to the present invention, a fu...  
WO/2013/042769
This aromatic amine derivative is represented by general formula (1). In general formula (1), R2, R3, R4, R5, R7, R8, R9, and R10 each independently are a hydrogen atom or a substituent group. In general formula (1): R1 and R6 are repres...  
WO/2013/041807
The present invention relates to compounds having the following formula (I-I): in which A represents a cycle chosen from the group comprising the aryl, heteroaryl, C5-8 cycloalkenyl, and heterocycloalkenyl groups, said cycle (A) being op...  
WO/2013/041895
The invention relates to novel compounds of general formula (I), and their preparation, pharmaceutical preparations containing compounds of general formula (I), and the use of these compounds in therapeutic procedures. The invention also...  
WO/2013/043131
Disclosed herein is a process for preparing 5-hydroxymethylfurfural comprising the step of contacting a carbohydrate and a Brønsted acid in an alcoholic solvent comprising an alcohol selected from the group consisting of secondary alcoh...  
WO/2013/042124
Compound of formula X wherein P1 is a fused-ring system comprising one 6-membered and two 5- membered rings; v indicates an S or R configuration; or individual isomers or pharmaceutically acceptable salts thereof, or mixtures thereof, in...  
WO/2013/042775
An aromatic amine derivative represented by general formula (1-1). In general formula (1-1), R2-R5 and R7-R10 are each independently a hydrogen atom or a substituent group. In general formula (1-1), R1 and R6 are represented by general f...  
WO/2013/042138
A process for the preparation of 4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl) tetrahydro-5-(lH-l,2,4-triazol-l-ylmefhyl) -3-furanyl]mefhoxy] phenyl] -1 -piperazinyl] phenyl]-2-[(lS,2S)-l-efhyl-2-hydroxypropyl]-2,4-dihydro-3H-l ,2,4-triazo...  
WO/2013/042124
Compound of formula X wherein P1 is a fused-ring system comprising one 6-membered and two 5- membered rings; v indicates an S or R configuration; or individual isomers or pharmaceutically acceptable salts thereof, or mixtures thereof, in...  
WO/2013/040068
The presently disclosed subject matter provides methods of preparing synthetic prostacyclin analogues, including Beraprost, either as racemic mixtures or as single stereoisomers. Also provided are novel synthetic intermediates for use in...  
WO/2013/039184
An aromatic amine derivative represented by general formula (1). In general formula (1), R1 to R10 each independently are a hydrogen atom or a substituent group. In general formula (1), any one of R1 to R10 is represented by general form...  
WO/2013/040540
A composition comprising between 95 and 100% biobased succinic acid, MAS or DAS wherein at least 75 % of the carbons are biobased.  

Matches 301 - 350 out of 14,060